GC
Gamida Cell
About
Gamida Cell is a cell therapy pioneer working to turn cells into powerful therapeutics. Our proprietary nicotinamide (NAM) technology expands the number of cells while maintaining their intrinsic properties to create potentially curative cell therapy products and candidates for patients with cancer. Our stem cell transplant therapy was approved by the US FDA in April 2023. Clinical study of our NK cell therapy candidate GDA-201 is ongoing.
Tags
Company Timeline
Funding rounds, employee growth, revenue, and exits over the same period. News mentions shown as markers.
No timeline data for this period
Score Breakdown
30Traction
35Team
30Visibility
6Profile
60Community
15Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Gamida Cell do?
Gamida Cell is a cell therapy pioneer working to turn cells into powerful therapeutics. Our proprietary nicotinamide (NAM) technology expands the number of cells while maintaining their intrinsic properties to create potentially curative cell therapy products and candidates for patients with cancer. Our stem cell transplant therapy was approved by the US FDA in April 2023. Clinical study of our NK cell therapy candidate GDA-201 is ongoing.
How much funding has Gamida Cell raised?
Gamida Cell has raised a total of $10M in funding. The most recent round on record is Post-IPO.
When was Gamida Cell founded?
Gamida Cell was founded in 1998.
What industry does Gamida Cell operate in?
Gamida Cell operates in Life Sciences.
What is Gamida Cell's current status?
Gamida Cell's current operating status is: Public.